Diagnostic Utility of a Clonality Test for Lymphoproliferative Diseases in Koreans Using the BIOMED-2 PCR Assay
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: A clonality test for immunoglobulin (IG) and T cell receptor (TCR) is a useful adjunctive method for the diagnosis of lymphoproliferative diseases (LPDs). Recently, the BIOMED-2 multiplex polymerase chain reaction (PCR) assay has been established as a standard method for assessing the clonality of LPDs. We tested clonality in LPDs in Koreans using the BIOMED-2 multiplex PCR and compared the results with those obtained in European, Taiwanese, and Thai participants. We also evaluated the usefulness of the test as an ancillary method for diagnosing LPDs. Methods: Two hundred and nineteen specimens embedded in paraffin, including 78 B cell lymphomas, 80 T cell lymphomas and 61 cases of reactive lymphadenitis, were used for the clonality test. Results: Mature B cell malignancies showed 95.7% clonality for IG, 2.9% co-existing clonality, and 4.3% polyclonality. Mature T cell malignancies exhibited 83.8% clonality for TCR, 8.1% co-existing clonality, and 16.2% polyclonality. Reactive lymphadenitis showed 93.4% polyclonality for IG and TCR. The majority of our results were similar to those obtained in Europeans. However, the clonality for IGK of B cell malignancies and TCRG of T cell malignancies was lower in Koreans than Europeans. Conclusions: The BIOMED-2 multiplex PCR assay was a useful adjunctive method for diagnosing LPDs.
Abstract
Background: A clonality test for immunoglobulin (IG) and T cell receptor (TCR) is a useful adjunctive method for the diagnosis of lymphoproliferative diseases (LPDs). Recently, the BIOMED-2 multiplex polymerase chain reaction (PCR) assay has been established as a standard method for assessing the clonality of LPDs. We tested clonality in LPDs in Koreans using the BIOMED-2 multiplex PCR and compared the results with those obtained in European, Taiwanese, and Thai participants. We also evaluated the usefulness of the test as an ancillary method for diagnosing LPDs. Methods: Two hundred and nineteen specimens embedded in paraffin, including 78 B cell lymphomas, 80 T cell lymphomas and 61 cases of reactive lymphadenitis, were used for the clonality test. Results: Mature B cell malignancies showed 95.7% clonality for IG, 2.9% co-existing clonality, and 4.3% polyclonality. Mature T cell malignancies exhibited 83.8% clonality for TCR, 8.1% co-existing clonality, and 16.2% polyclonality. Reactive lymphadenitis showed 93.4% polyclonality for IG and TCR. The majority of our results were similar to those obtained in Europeans. However, the clonality for IGK of B cell malignancies and TCRG of T cell malignancies was lower in Koreans than Europeans. Conclusions: The BIOMED-2 multiplex PCR assay was a useful adjunctive method for diagnosing LPDs.
참고문헌 (25)
- "National Cancer Informantion Center now covers statistics of cancer prevalence" (2012)[URL]
- Gleissner B, "Detection of immunoglobulin heavy chain genes rearrangements in B-cell leukemias, lymphomas, multiple myelomas, monoclonal and polyclonal gammopathies", Leuk Lymphoma, 39, pp.151~155 (2000)
- Langerak AW, "The role of molecular analysis of immunoglobulin and T cell receptor gene rearrangements in the diagnosis of lymphoproliferative disorders", J Clin Pathol, 54, pp.565~567 (2001)
- Sen F, "Molecular genetic methods in the diagnosis of hematologic neoplasms", Semin Diagn Pathol, 19, pp.72~93 (2002)
- Sioutos N, "Polymerase chain reaction versus Southern blot hybridization: detection of immunoglobulin heavy-chain gene rearrangements", Diagn Mol Pathol, 4, pp.8~13 (1995)
- Achille A, "Routine application of polymerase chain reaction in the diagnosis of monoclonality of B-cell lymphoid proliferations", Diagn Mol Pathol, 4, pp.14~24 (1995)
- Benhattar J, "Improved polymerase chain reaction detection of clonal T-cell lymphoid neoplasms", Diagn Mol Pathol, 4, pp.108~112 (1995)
- Cho EY, "Diagnostic utility of polymerase chain reaction-based clonality analysis for immunoglobulin heavy chain gene and T-cell receptor gamma chain gene rearrangement in lymphoid neoplasms", Korean J Pathol, 35, pp.461~469 (2001)
- Fodinger M, "Multiplex PCR for rapid detection of T-cell receptor-gamma chain gene rearrangements in patients with lymphoproliferative diseases", Br J Haematol, 94, pp.136~139 (1996)
- Ilyas M, "The use of the polymerase chain reaction in the diagnosis of B-cell lymphomas from formalin-fixed paraffin-embedded tissue", Histopathology, 26, pp.333~338 (1995)
- Lozano MD, "Clonality analysis of B-lymphoid proliferations using the polymerase chain reaction", Cancer, 77, pp.1349~1355 (1996)
- Brüggemann M, "Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936", Leukemia, 21, pp.215~221 (2007)
- Droese J, "Validation of BIOMED-2 multiplex PCR tubes for detection of TCRB gene rearrangements in T-cell malignancies", Leukemia, 18, pp.1531~1538 (2004)
- Liu H, "A practical strategy for the routine use of BIOMED-2 PCR assays for detection of B- and T-cell clonality in diagnostic haematopathology", Br J Haematol, 138, pp.31~43 (2007)
- van Krieken JH, "Improved reliability of lymphoma diagnostics via PCR-based clonality testing: report of the BIOMED-2 Concerted Action BHM4-CT98-3936", Leukemia, 21, pp.201~206 (2007)
- McClure RF, "Validation of immunoglobulin gene rearrangement detection by PCR using commercially available BIOMED-2 primers", Leukemia, 20, pp.176~179 (2006)
- Chen YL, "BIOMED-2 protocols to detect clonal immunoglobulin and T-cell receptor gene rearrangements in B- and T-cell lymphomas in southern Taiwan", Leuk Lymphoma, 51, pp.650~655 (2010)
- Pongpruttipan T, "Extranodal NK", T-cell lymphoma, nasal type, includes cases of natural killer cell and alphabeta, gammadelta, and alphabeta, Am J Surg Pathol, pp.2012, 36[DOI]
- van Dongen JJ, "Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-C T98-3936", Leukemia, 17, pp.2257~2317 (2003)
- Langerak AW, "Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls: a report of the BIOMED-2 Concerted Action BMH4-CT98-3936", Leukemia, 21, pp.222~229 (2007)
- Evans PA, "Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936", Leukemia, 21, pp.207~214 (2007)
- 성지연, "면역글로불린 유전자 재배열 분석법: BIOMED-2와 통상적 Nested PCR법의 비교", Laboratory Medicine Online, 1(4), pp.195~201 (2011), 대한진단검사의학회
- "National Center for Biotechnology Information now covers SNP"[URL]
- Fairhurst RM, "A DNA repair abnormality specific for rearranged immunoglobulin variable genes in germinal center B cells", Mol Immunol, 33, pp.231~244 (1996)
- Vershenya S, "Dose response for T-cell receptor (TCR) mutants in patients repeatedly treated with 131I for thyroid cancer", Mutat Res, 548, pp.27~33 (2004)